test

Adam Koppel

@Bain Capital Life Sciences Investors, Llc

Latest period2024 - Q3ReportedManaged Assets$961.176MTotal holdings24
Assets growth rate5.53%Assets growth rate (2-Q avg)-10.63%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Bain Capital Life Sciences Investors, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 24 positions.

Assets under management

The assets under management (AUM) of Bain Capital Life Sciences Investors, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 961.176M in assets, with a quarterly growth rate of 5.53% and a 2-quarter average growth rate of -10.63%. The portfolio is managed by Adam Koppel, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
MRNSMarinus Pharmaceuticals Inc
Recent Activity
Increased 18.78%
0.5%
$4.74M
2.693M shares@ $1.77 avg price
XLOXilio Therapeutics Inc
Recent Activity
Increased 20.65%
0.38%
$3.597M
4.567M shares@ $0.79 avg price
IVVDInvivyd Inc
Recent Activity
0.2%
$1.836M
1.8M shares@ $1.03 avg price
NAMSWNewamsterdam Pharma Company
Recent Activity
0.08%
$700,000
100,000 shares@ $7.0 avg price